Cargando…
Increased circulating β(2)-adrenergic receptor autoantibodies are associated with smoking-related emphysema
Smoking is a dominant risk factor for chronic obstructive pulmonary disease (COPD) and emphysema, but not every smoker develops emphysema. Immune responses in smokers vary. Some autoantibodies have been shown to contribute to the development of emphysema in smokers. β(2)-adrenergic receptors (β(2)-A...
Autores principales: | Hu, Jia-yi, Liu, Bei-bei, Du, Yi-peng, Zhang, Yuan, Zhang, Yi-wei, Zhang, You-yi, Xu, Ming, He, Bei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338268/ https://www.ncbi.nlm.nih.gov/pubmed/28262783 http://dx.doi.org/10.1038/srep43962 |
Ejemplares similares
-
Author Correction: Increased circulating β2-adrenergic receptor autoantibodies are associated with smoking-related emphysema
por: Hu, Jia-yi, et al.
Publicado: (2020) -
Elevated β1-Adrenergic Receptor Autoantibody Levels Increase Atrial Fibrillation Susceptibility by Promoting Atrial Fibrosis
por: Shang, Luxiang, et al.
Publicado: (2020) -
Circulating β(1) Adrenergic Autoantibodies from Patients with Chronic Periodontitis Interact with Gingival Fibroblasts
por: Sterin-Borda, Leonor, et al.
Publicado: (2009) -
Impact of human autoantibodies on β(1)-adrenergic receptor conformation, activity, and internalization
por: Bornholz, Beatrice, et al.
Publicado: (2013) -
Honokiol Protects against Anti-β1-Adrenergic Receptor Autoantibody-Induced Myocardial Dysfunction via Activation of Autophagy
por: Wei, Xi-qing, et al.
Publicado: (2018)